Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

EVEX vs RCAT: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

RCAT Wins Head-to-Head Institutional Verdict (4–1 across 6 Pillars · 3–4 Matrix Metrics)

RCAT Overall Winner 6-Pillar Tally: EVEX 1 – 4 RCAT (1 Tie) Matrix Metrics: EVEX 4 – 3 RCAT

As of Nov 16, 2026, Red Cat Holdings, Inc. (RCAT) is the stronger overall head-to-head candidate over Eve Holding, Inc. (EVEX) in the Tradestie Institutional Equity Comparison Engine, winning 3–4 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Balance Sheet & Cash Flow). EVEX carries a Unified Composite Score of 41.3/100 (SELL) at $1.70 (N/M Forward P/E, 0.0% operating margin), whereas RCAT carries 53.8/100 (HOLD) at $3.59 (N/M Forward P/E, -150.2% operating margin).

  • Technical & Structure Timing Caution: EVEX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 42.8); meanwhile RCAT is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 33.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About EVEX vs RCAT
EVEX NYSE
Eve Holding, Inc.
Aircraft
$1.70
+2.41% 1D
Market Cap $597.7M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 2.71β · 96% Vol
Unified Composite Score
41.3 / 100 SELL
Tech 20.0 Fund 45.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -15.6%), weak momentum, RSI 43
RSI-14: 42.8 · SMA20: $1.68 · SMA50: $1.81
RCAT NASDAQ Head-to-Head Winner
Red Cat Holdings, Inc. Common Stock
Services-Prepackaged Software
$3.59
-5.53% 1D
Market Cap $600.9M
TTM Revenue $72M
Forward P/E N/M
Beta / 30D Vol 3.58β · 123% Vol
Unified Composite Score
53.8 / 100 HOLD
Tech 43.0 Fund 59.0 Flow 70.0 Mom 68.9
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -26.6%), weak momentum, RSI 33
RSI-14: 33.4 · SMA20: $4.32 · SMA50: $5.64

6-Pillar Scorecard Institutional Category Breakdown (EVEX 1 – 4 RCAT)

Columns: Metric · EVEX · RCAT
1. Valuation Multiples RCAT
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M 4.1x
2. Growth & Scale RCAT
Revenue Growth (YoY) +0.0% +527.2%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) N/A $72M
Market Cap $597.7M $600.9M
3. Profitability & Quality EVEX
Gross Margin N/A 9.7%
Operating Margin 0.0% -150.2%
Net Profit Margin 0.0% -136.3%
Return on Equity (ROE) -300.9% -34.4%
4. Balance Sheet & Cash Flow RCAT
Cash Generation (TTM) N/A -$158M
Cash Flow Margin N/A N/A
Net Cash / Leverage -300.9% ROE $311M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning RCAT
Options Structure Phase UNCLASSIFIED BREAKDOWN
Current IV / %ile 72.3% (50th %ile) 87.3% (28th %ile)
Put/Call OI Skew N/A 0.91x (Balanced)
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Aerospace & Defense Operator Aerospace & Defense Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: EVEX (4) vs RCAT (3)
Institutional Metric EVEX RCAT Criterion Row Edge
Market Capitalization
Scale
$597.7M $600.9M Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+0.0% +527.2% Higher Growth RCAT
Operating Margin (TTM)
Profitability
0.0% -150.2% Higher Margin EVEX
Net Profit Margin
Profitability
0.0% -136.3% Higher Margin EVEX
Return on Equity (ROE)
Capital Efficiency
-300.9% -34.4% Higher ROE RCAT
52-Week Range Position
Momentum
8% ($1–$5) 2% ($3–$19) Stronger Trend EVEX
Beta / 30D Volatility
Risk Regime
2.71β · 96% Vol 3.58β · 123% Vol Lower Realized Risk EVEX
Unified Institutional Score
Composite Signal
41.3 / 100 (SELL) 53.8 / 100 (HOLD) Higher Composite RCAT
Trailing 12M Revenue (USD)
Operating Scale
N/A $72M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 9.7% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · 4.1x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (-300.9% ROE) -$158M ($311M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon EVEX +28.88 pp
EVEX: +4.94% · RCAT: -23.94%
3M Horizon EVEX +28.97 pp
EVEX: -35.85% · RCAT: -64.82%
6M Horizon EVEX +18.83 pp
EVEX: -40.97% · RCAT: -59.8%
1Y Horizon RCAT +5.51 pp
EVEX: -59.13% · RCAT: -53.62%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on EVEX vs RCAT. Trailing 12-month operating profitability (EVEX 0.0% vs RCAT -150.2%) and valuation multiples (EVEX N/M vs RCAT N/M Forward P/E) are benchmarked directly in Pillar 4 below.

EVEX ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. Margin0.0%
ROE / Fwd P/E-300.9% · N/M
RCAT ADR TTM Benchmark FX-Normalized USD
TTM Revenue$72M
Gross Margin9.7%
Op. Margin-150.2%
ROE / Fwd P/E-34.4% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
EVEX UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 72.3%
IV Percentile 50th %ile
Put/Call OI Skew N/A
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact EVEX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
RCAT BREAKDOWN
116d in phase · OBV NEUTRAL
Current IV 87.3%
IV Percentile 28th %ile
Put/Call OI Skew 0.91x (Balanced)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact RCAT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
EVEX Moat Profile Cyclical / Execution-Driven Positioning
Aerospace & Defense Operator
Competes within the Aerospace & Defense value chain with $597.7M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
RCAT Moat Profile Cyclical / Execution-Driven Positioning
Aerospace & Defense Operator
Competes within the Aerospace & Defense value chain with $600.9M market capitalization and -150.2% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ EVEX vs RCAT Key Questions & Quantitative Answers

As of Nov 16, 2026, Red Cat Holdings, Inc. (RCAT) is the stronger overall head-to-head candidate over Eve Holding, Inc. (EVEX) in the Tradestie Institutional Equity Comparison Engine, winning 3–4 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Balance Sheet & Cash Flow). EVEX carries a Unified Composite Score of 41.3/100 (SELL) at $1.70 (N/M Forward P/E, 0.0% operating margin), whereas RCAT carries 53.8/100 (HOLD) at $3.59 (N/M Forward P/E, -150.2% operating margin). Technical & Structure Timing Caution: EVEX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 42.8); meanwhile RCAT is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 33.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

RCAT leads the Growth & Scale pillar: EVEX posts +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin), compared with RCAT at +527.2% YoY revenue growth and +0.0% YoY earnings growth on $72M TTM revenue (9.7% gross margin, -150.2% operating margin). On trailing 12-month operating scale, EVEX generates N/A in USD-normalized revenue versus $72M for RCAT. In operating R&D and SG&A reinvestment, EVEX deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for RCAT.

RCAT screens cheaper on headline valuation multiples. EVEX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas RCAT trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 4.1x EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against EVEX (-300.9% ROE) versus RCAT (-34.4% ROE) capital efficiency.

In options market volatility and institutional positioning, EVEX carries 72.3% implied volatility (50th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.71β · 96% Vol realized risk). By comparison, RCAT carries 87.3% implied volatility (28th %ile, Balanced (25th–60th %ile)), a 0.91x (Balanced) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (3.58β · 123% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.